OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
October 11, 2005
A look at what the advent of generic antiretroviral drugs could mean for the industry.
Experts are thrilled about the development of a new iron chelation drug that could be taken orally, changing the lives of patients who need chronic blood transfusions.
ABthrax takes advantage of new knowledge about anthrax to fight the bacteria’s lethal toxin.